Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy

American Journal of Kidney Diseases

Volumn 64, Issue 2, 2014, Pages 181-186

  Kalantar Zadeh, Kamyar ^a,b   Unruh, Mark ^c   Zager, Philip G ^c   Kovesdy, Csaba P ^d   Bargman, Joanne M ^e   Chen, Jing ^f   Sankarasubbaiyan, Suresh ^g   Shah, Gaurang ^b   Golper, Thomas ^h   Sherman, Richard A ⁱ   Goldfarb, David S ^j  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f FUDAN UNIVERSITY   (China)

^g Nephrolife Dialysis   (India)

^h VANDERBILT UNIVERSITY   (United States)

ⁱ ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^j VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

end stage renal disease; incremental dialysis; incremental hemodialysis; Index Words; kidney replacement therapy; renal replacement therapy; residual kidney function; Transition of care

Indexed keywords

C REACTIVE PROTEIN; PHOSPHORUS; POTASSIUM;

ARTICLE; BODY SIZE; CARDIOVASCULAR SYMPTOM; COMORBIDITY; DECISION SUPPORT SYSTEM; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCREMENTAL HEMODIALYSIS; KIDNEY FUNCTION; MORTALITY; NUTRITIONAL STATUS; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; RESIDUAL KIDNEY FUNCTION; URINE VOLUME; VASCULAR ACCESS;

END-STAGE RENAL DISEASE; INCREMENTAL DIALYSIS; INCREMENTAL HEMODIALYSIS; KIDNEY REPLACEMENT THERAPY; RENAL REPLACEMENT THERAPY; RESIDUAL KIDNEY FUNCTION; TRANSITION OF CARE;

HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84905120191     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.04.019     Document Type: Article

References (42)

1. A.J. Collins, R.N. Foley, and C. Herzog et al. US Renal Data System 2012 annual data report Am J Kidney Dis 61 suppl 1 2013 e1 e480
2. M.Z. Molnar, A.O. Ojo, S. Bunnapradist, C.P. Kovesdy, and K. Kalantar-Zadeh Timing of dialysis initiation in transplant-naive and failed transplant patients Nat Rev Nephrol 8 2012 284 292
3. B.D. Bradbury, R.B. Fissell, and J.M. Albert et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Clin J Am Soc Nephrol 2 2007 89 99
4. L.R. Lukowsky, L. Kheifets, O.A. Arah, A.R. Nissenson, and K. Kalantar-Zadeh Patterns and predictors of early mortality in incident hemodialysis patients: new insights Am J Nephrol 35 2012 548 558
5. C.M. Rhee, and K. Kalantar-Zadeh Transition to dialysis: controversies in its timing and modality Introduction. Semin Dial 26 2013 641 643
6. C.M. Rhee, M. Unruh, J. Chen, C.P. Kovesdy, P. Zager, and K. Kalantar-Zadeh Infrequent dialysis: a new paradigm for hemodialysis initiation Semin Dial 26 2013 720 727
7. E. Streja, C.P. Kovesdy, and S. Greenland et al. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis Am J Kidney Dis 52 2008 727 736
8. E. Vilar, and K. Farrington Emerging importance of residual renal function in end-stage renal failure Semin Dial 24 2011 487 494
9. T. Hyodo, and N. Koutoku Preservation of residual renal function with HDF Contrib Nephrol 168 2011 204 212
10. Z. Diao, D. Zhang, W. Dai, J. Ding, A. Zhang, and W. Liu Preservation of residual renal function with limited water removal in hemodialysis patients Ren Fail 33 2011 875 877
11. Y.F. Lin, J.W. Huang, and M.S. Wu et al. Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis Nephrology (Carlton) 14 2009 59 64
12. D.E. Rifkin, S.G. Coca, and K. Kalantar-Zadeh Does AKI truly lead to CKD? J Am Soc Nephrol 23 2012 979 984
13. J.T. Daugirdas, T. Greene, and M.V. Rocco et al. Effect of frequent hemodialysis on residual kidney function Kidney Int 83 5 2013 949 958
14. N.S. Bricker, P.A. Morrin, and S.W. Kime Jr. The pathologic physiology of chronic Bright's disease. An exposition of the "intact nephron hypothesis." Am J Med 28 1960 77 98
15. T. Shafi, B.G. Jaar, and L.C. Plantinga et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study Am J Kidney Dis 56 2010 348 358
16. W.M. van der Wal, M. Noordzij, and F.W. Dekker et al. Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model Nephrol Dial Transplant 26 2011 2978 2983
17. M. Wang, L. You, and H. Li et al. Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function Clin J Am Soc Nephrol 2012
18. J.L. Bragg-Gresham, R.B. Fissell, and N.A. Mason et al. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS) Am J Kidney Dis 49 2007 426 431
19. F. Termorshuizen, J.C. Korevaar, F.W. Dekker, J.G. van Manen, E.W. Boeschoten, and R.T. Krediet The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2 Am J Kidney Dis 41 2003 1293 1302
20. J.M. Bargman, K.E. Thorpe, and D.N. Churchill Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA Study J Am Soc Nephrol 12 2001 2158 2162
21. C.C. Szeto, T.Y. Wong, K.M. Chow, C.B. Leung, M.C. Law, and P.K. Li Independent effects of renal and peritoneal clearances on the mortality of peritoneal dialysis patients Perit Dial Int 24 2004 58 64
22. J.R. Curtis, J.B. Eastwood, and E.K. Smith et al. Maintenance haemodialysis Q J Med 38 1969 49 89
23. C.R. Blagg Hemodialysis 1991 Blood Purif 10 1992 22 29
24. X. Lin, Y. Yan, and Z. Ni et al. Clinical outcome of twice-weekly hemodialysis patients in Shanghai Blood Purif 33 2012 66 72
25. J.A. Hanson, T.E. Hulbert-Shearon, and A.O. Ojo et al. Prescription of twice-weekly hemodialysis in the USA Am J Nephrol 19 1999 625 633
26. T.A. Golper Incremental dialysis J Am Soc Nephrol 9 suppl 1 1998 S107 S111
27. J.M. Burkart, and T.A. Golper Should we treat patients with incremental dialysis prescriptions? Blood Purif 18 2000 298 303
28. National Kidney Foundation K/DOQI clinical practice guidelines for hemodialysis adequacy Am J Kidney Dis 1998
29. European Best Practice Guidelines Expert Group on Haemodialysis. European best practice guidelines for haemodialysis (Part 1) Nephrol Dial Transplant 17 suppl 7 2002 S16 S31
30. K. Kalantar-Zadeh, and F. Casino Let's give twice-weekly hemodialysis a chance: revisiting the taboo Nephrol Dial Transplant 2014 In press
31. H. Alston Conservative care for end-stage kidney disease: joint medical conference with the Renal Association, British Geriatrics Society and Association for Palliative Medicine Clin Med 13 2013 383 386
32. S.J. Rosansky, G. Cancarini, and W.F. Clark et al. Dialysis initiation: what's the rush? Semin Dial 26 2013 650 657
33. R. Mehrotra, M. Rivara, and J. Himmelfarb Initiation of dialysis should be timely: neither early nor late Semin Dial 26 2013 644 649
34. R.N. Foley, D.T. Gilbertson, T. Murray, and A.J. Collins Long interdialytic interval and mortality among patients receiving hemodialysis N Engl J Med 365 2011 1099 1107
35. K. Kalantar-Zadeh, D.L. Regidor, and C.P. Kovesdy et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis Circulation 119 2009 671 679
36. C.P. Kovesdy, D.L. Regidor, and R. Mehrotra et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients Clin J Am Soc Nephrol 2 2007 999 1007
37. J. Hayes, K. Kalantar-Zadeh, J.L. Lu, S. Turban, J.E. Anderson, and C.P. Kovesdy Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race Nephron Clin Pract 120 2012 c8 c16
38. K. Torlen, K. Kalantar-Zadeh, M.Z. Molnar, T. Vashistha, and R. Mehrotra Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort Clin J Am Soc Nephrol 7 2012 1272 1284
39. D.J. Buysse, L. Yu, and D.E. Moul et al. Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments Sleep 33 2010 781 792
40. Y.L. Ow, J. Thumboo, D. Cella, Y.B. Cheung, K. Yong Fong, and H.L. Wee Domains of health-related quality of life important and relevant to multiethnic english-speaking Asian systemic lupus erythematosus patients: a focus group study Arthritis Care Res 63 2011 899 908
41. A. Ghaffari, K. Kalantar-Zadeh, J. Lee, F. Maddux, J. Moran, and A. Nissenson PD first: peritoneal dialysis as the default transition to dialysis therapy Semin Dial 26 2013 706 713
42. Kalantar-Zadeh K, Casino FG. Let us give twice-weekly hemodialysis a chance: revisiting the taboo [published online ahead of print April 29, 2014]. Nephrol Dial Transplant. http://dx.doi.org/10.1093/ndt/gfu096.